These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
824 related articles for article (PubMed ID: 2872226)
1. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
2. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [TBL] [Abstract][Full Text] [Related]
3. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus. Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871 [TBL] [Abstract][Full Text] [Related]
5. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly. Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing hormone infusion in patients with active acromegaly. Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362 [TBL] [Abstract][Full Text] [Related]
7. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420 [TBL] [Abstract][Full Text] [Related]
8. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly. Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543 [TBL] [Abstract][Full Text] [Related]
9. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly. Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966 [TBL] [Abstract][Full Text] [Related]
11. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426 [TBL] [Abstract][Full Text] [Related]
12. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration. Candrina R Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962 [TBL] [Abstract][Full Text] [Related]
13. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly. Watanobe H; Tamura T Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355 [TBL] [Abstract][Full Text] [Related]
16. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly. Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513 [TBL] [Abstract][Full Text] [Related]
17. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones. Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly. Kelijman M; Williams TC; Downs TR; Frohman LA J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171 [TBL] [Abstract][Full Text] [Related]
20. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell. Beck-Peccoz P; Bassetti M; Spada A; Medri G; Arosio M; Giannattasio G; Faglia G J Clin Endocrinol Metab; 1985 Sep; 61(3):541-6. PubMed ID: 2410443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]